According to a specialized industrial analytics report published by Fact.MR, the global GABA supplement market is valued at USD 51.2 million in 2024. Driven by a widespread increase in modern, high-stress lifestyles, a rising global prevalence of insomnia and anxiety disorders, and an active preference for non-habit-forming relaxation aids, the industry is projected to reach a milestone...